Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram

Showing results (421-430 of 24,158) with videos related to

Pageof 2,416
Sort By:
ACS Medicinal Chemistry Letters|March 20, 2024
Novel AT2R Antagonists for Treating Chronic PainRam W Sabnis
ACS Medicinal Chemistry Letters|May 15, 2024
Novel Exatecan-Derived Topoisomerase-1 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|May 15, 2024
Novel Myeloperoxidase Inhibitors for Treating Multiple DiseasesRam W Sabnis
Biochemical Society Transactions|May 8, 2024
An emerging role for tissue plasticity in developmental precisionSundar Ram Naganathan
ACS Medicinal Chemistry Letters|November 17, 2023
Emopamil-Binding Protein Inhibitors for Treating Multiple SclerosisRam W Sabnis
ACS Medicinal Chemistry Letters|October 18, 2023
Emopamil-Binding Protein Inhibitors for Treating Multiple SclerosisRam W Sabnis
ACS Medicinal Chemistry Letters|October 18, 2023
Novel Indazole Compounds as TEAD Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|October 18, 2023
Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating GlioblastomaRam W Sabnis
ACS Medicinal Chemistry Letters|September 22, 2023
Novel P2X3 Inhibitors for Treating Neurogenic DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|September 22, 2023
Novel Compounds for Preventing SARS-CoV-2 Viral Replication and Treating COVID-19Ram W Sabnis
Pageof 2,416

Showing results (421-430 of 24,158) with videos related to

Sort By:
Pageof 2,416
ACS Medicinal Chemistry Letters|March 20, 2024
Novel AT2R Antagonists for Treating Chronic PainRam W Sabnis
ACS Medicinal Chemistry Letters|May 15, 2024
Novel Exatecan-Derived Topoisomerase-1 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|May 15, 2024
Novel Myeloperoxidase Inhibitors for Treating Multiple DiseasesRam W Sabnis
Biochemical Society Transactions|May 8, 2024
An emerging role for tissue plasticity in developmental precisionSundar Ram Naganathan
ACS Medicinal Chemistry Letters|November 17, 2023
Emopamil-Binding Protein Inhibitors for Treating Multiple SclerosisRam W Sabnis
ACS Medicinal Chemistry Letters|October 18, 2023
Emopamil-Binding Protein Inhibitors for Treating Multiple SclerosisRam W Sabnis
ACS Medicinal Chemistry Letters|October 18, 2023
Novel Indazole Compounds as TEAD Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|October 18, 2023
Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating GlioblastomaRam W Sabnis
ACS Medicinal Chemistry Letters|September 22, 2023
Novel P2X3 Inhibitors for Treating Neurogenic DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|September 22, 2023
Novel Compounds for Preventing SARS-CoV-2 Viral Replication and Treating COVID-19Ram W Sabnis
Pageof 2,416